Secukinumab as a potential trigger of inflammatory bowel disease in ankylosing spondylitis or psoriatic arthritis patients.
Onac IA, Clarke BD, Tacu C, Lloyd M, Hajela V, Batty T, Thoroughgood J, Smith S, Irvine H, Hill D, Baxter G, Horwood N, Mahendrakar S, Rajak R, Griffith S, Kiely PDW, Galloway J.
Onac IA, et al. Among authors: lloyd m.
Rheumatology (Oxford). 2021 Nov 3;60(11):5233-5238. doi: 10.1093/rheumatology/keab193.
Rheumatology (Oxford). 2021.
PMID: 33677579